Biotalys Celebrates Regulatory Victory for EVOCA
Biotalys, a prominent AgTech firm, is thrilled to announce a significant milestone: the U.S. Environmental Protection Agency (EPA) has approved its first biofungicide, EVOCA™. This groundbreaking approval comes as a result of Biotalys’ innovative AGROBODY™ technology platform, making EVOCA the first protein-based biofungicide approved by the EPA.
Understanding EVOCA: A Breakthrough in Crop Protection
EVOCA is designed as a precise biocontrol solution, targeting prevalent fungal pathogens like botrytis (grey mold) and powdery mildew that devastate high-value fruits and vegetables. Unlike conventional fungicides, EVOCA is engineered to minimize ecological impact and safeguard beneficial organisms, providing an environmentally friendly alternative for farmers.
Advancements in Registration and Future Developments
With this pivotal EPA approval, Biotalys is now poised to advance state registration processes in key agricultural states such as California and Florida, known for their substantial fruit and vegetable production.
In Europe, EVOCA is currently navigating the peer review process, with the Netherlands acting as the rapporteur state, proposing its approval contingent on further data submission. This step highlights the growing recognition of EVOCA’s potential impact in various markets.
Next-Generation Product: EVOCA NG
Beyond just EVOCA, Biotalys is gearing up for the completion of regulatory submissions for EVOCA NG, its next-generation product. This formulation retains the same active ingredient as EVOCA but incorporates enhanced production methods, promising a faster regulatory review. Biotalys anticipates registering EVOCA NG in the U.S. around 2028-29 and subsequently in the EU and Brazil.
Key Benefits to Growers
EVOCA stands out not only for its innovative approach to pest control but also offers tangible benefits to growers:
- Flexible application in both pre- and post-harvest stages, suitable for a diverse range of crops.
- Compatibility with various application methods, enabling seamless integration into existing farming practices.
- A fresh mode of action that aids in managing resistance, setting it apart from traditional fungicides.
Regulatory Exemptions and Safety Profile
In a noteworthy development, the EPA has finalized a rule exempting EVOCA’s active ingredient residues on treated crops from standard tolerance requirements. This decision underscores EVOCA's exemplary safety profile, allowing for broader acceptance among growers.
A Vision for Sustainable Agriculture
Kevin Helash, CEO of Biotalys, emphasized the impact of this approval, highlighting EVOCA as a vital tool for farmers, aimed at ensuring crop health while protecting the environment. “This approval is a testament to our technology's potential to innovate agriculture,” he stated. “Our unique platform opens avenues for discovering novel modes of action in the future.”
About Biotalys
As a leader in agricultural technology, Biotalys merges effective chemical practices with sustainable biological solutions. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), the company operates from Ghent, Belgium, and focuses on developing distinctive biocontrol products to enhance crop protection.
For further information, Biotalys can be contacted by:
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com
Frequently Asked Questions
What is EVOCA?
EVOCA is a revolutionary protein-based biofungicide created by Biotalys, aimed at combating fungal diseases in crops.
What are the advantages of using EVOCA?
EVOCA offers flexible application options, compatibility with various methods, and an innovative mode of action against resistance buildup.
When will EVOCA NG be available?
Biotalys expects to register EVOCA NG in the U.S. between 2028-29, with further developments in the EU and Brazil to follow.
How does EVOCA impact the environment?
EVOCA is developed to minimize ecological disruption, making it a sustainable choice for farmers looking to protect crops while preserving beneficial organisms.
Who should I contact for more information about Biotalys?
For inquiries, you can reach out to Toon Musschoot, the Head of IR & Communication, via email at IR@biotalys.com or by phone at +32 (0)9 274 54 00.
